Logo-apb
Adv Pharm Bull. 2024;14(3): 574-590. doi: 10.34172/apb.2024.052
PMID: 39494266        PMCID: PMC11530882

Review Article

Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment

Parisa Kangari 1,2 * ORCID, Reza Salahlou 3,4, Somayeh Vandghanooni 2 * ORCID

Cited by CrossRef: 0


1- Radzikowska-Bűchner E, Radej S, Niezabitowska E, Sitarz R, Szewc M. Potential of Using New Indole- and Benzimidazo[1,2-C]quinazolines in Anticancer Therapy Based on Mesenchymal Stem Cells. CMAR. 2025;Volume 17:1087 [Crossref]
2- Gao C, Wang X, Yan H, Zeng G, Chen Y, Gao J. Exosome-Delivered Hsa_Circ_0000116 Facilitates Osteosarcoma Cell Malignancy via PI3K/Akt/mTOR and p38/MAPK Pathways. DNA and Cell Biology. 2025;44(3):153 [Crossref]
3- Guo X, Liu B, Xu P, Chen H, Gao J, Yao D, Li X, Wang Y, Wang T, Yao H, Qiao S, Huge J, Yuan J. Research on the mechanism of human umbilical cord mesenchymal stem cells and their extracellular vesicles in the treatment of common reproductive diseases. Stem Cell Res Ther. 2025;16(1) [Crossref]
4- Solopov M, Chechekhina E, Turchin V, Popandopulo A, Filimonov D, Burtseva A, Ishchenko R. Current Trends and Future Opportunities of AI-Based Analysis in Mesenchymal Stem Cell Imaging: A Scoping Review. J Imaging. 2025;11(10):371 [Crossref]